Death’s legal definition must be responsive to advances in technology, and it must delineate between life and death. Knowing where to draw the line is difficult.
AMA J Ethics. 2020;22(12):E1055-1061. doi:
10.1001/amajethics.2020.1055.
Amy Scharf, MS, Louis Voigt, MD, Santosha Vardhana, MD, PhD, Konstantina Matsoukas, MLIS, Lisa M. Wall, PhD, RN, CNS, AOCNS, HEC-C, Maria Arevalo, RN, OCN, and Lisa C. Diamond, MD, MPH
Patients’ cultural, religious, and social norms deserve respect, but some decisions’ effects on patients’ outcomes can be unjust and ethically troubling.
AMA J Ethics. 2021;23(2):E97-108. doi:
10.1001/amajethics.2021.97.
Dr Ariane Lewis discusses how we can navigate uncertainty and ambiguity about brain death by understanding clinical criteria for brain death determination and how our approaches to death are culturally and socially situated.
Pablo A. Ormachea, JD, Sasha Davenport, Gabe Haarsma, PhD, Anna Jarman, Howard Henderson, PhD, and David M. Eagleman, PhD
A new neuropsychological, game-based test battery to measure traits predictive of recidivism holds promise for individually tailoring criminal sentences.
AMA J Ethics. 2016;18(3):243-251. doi:
10.1001/journalofethics.2016.18.3.stas1-1603.
Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences.
AMA J Ethics. 2021;23(7):E537-541. doi:
10.1001/amajethics.2021.537.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.